Skip Nav Destination
Issues
Review
Research Articles
The Impact of Smoking Status, Disease Stage, and Index Tumor Site on Second Primary Tumor Incidence and Tumor Recurrence in the Head and Neck Retinoid Chemoprevention Trial1
Fadlo R. Khuri; Edward S. Kim; J. Jack Lee; Rodger J. Winn; Steven E. Benner; Scott M. Lippman; Karen K. Fu; Jay S. Cooper; Everett E. Vokes; Robert M. Chamberlain; Brendell Williams; Thomas F. Pajak; Helmuth Goepfert; Waun K. Hong
Protein Adducts of 1,4-Benzoquinone and Benzene Oxide among Smokers and Nonsmokers Exposed to Benzene in China1
Karen Yeowell-O’Connell; Nathaniel Rothman; Suramya Waidyanatha; Martyn T. Smith; Richard B. Hayes; Guilan Li; William E. Bechtold; Mustafa Dosemeci; Luoping Zhang; Songnian Yin; Stephen M. Rappaport
Human Lung Microsomal Cytochrome P4501A1 (CYP1A1) Activities: Impact of Smoking Status and CYP1A1, Aryl Hydrocarbon Receptor, and Glutathione S-Transferase M1 Genetic Polymorphisms1
Graeme B. J. Smith; Patricia A. Harper; Judy M. Y. Wong; Maria S. M. Lam; Ken R. Reid; Dimitri Petsikas; Thomas E. Massey
Short Communications
Null Results in Brief
Advertisement
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.